Going from 2.5 to 7.5 on Mounjaro: what the titration schedule actually means

Step 1, why 2.5 mg exists (and what it is not)

The 2.5 mg starting pen is a tolerability dose. Its job is to introduce tirzepatide to your system gradually, giving the gut time to adapt to a medicine that slows gastric emptying and changes how hunger signals reach the brain. Most people notice little appetite suppression at this level, which surprises them, but that is expected. The Mounjaro prescribing information makes clear that 2.5 mg is not a therapeutic weight-loss dose; meaningful appetite change typically comes at higher levels.

Nausea, loose stools and reflux are the most common early side effects, and they tend to be at their worst when the dose changes. Spending four weeks at 2.5 mg substantially reduces the chances of severe symptoms when you step up. Rushing through this stage frequently leads to the opposite outcome, worse side effects, more missed doses and, ultimately, slower progress.

If you find 2.5 mg genuinely comfortable after four weeks, that is the green light your prescriber is looking for before moving forward. If side effects are still noticeable, staying put for another four weeks is not unusual. You can read about the full range of available strengths on the Mounjaro doses guide.

Step 2, the move to 5 mg (the step you cannot skip)

The standard next step is 5 mg, and this is where the question of going from 2.5 mg straight to 7.5 mg becomes important. The licensed schedule, as described by the NHS tirzepatide medicines page, does not include a direct 2.5-to-7.5 jump, 5 mg is the bridging dose, and it serves a purpose.

At 5 mg the therapeutic effect becomes more noticeable for most people. Appetite reduction tends to be clearer, and the digestive system is still adjusting. This is also the point where some people consider whether they want to stay longer before moving again. The 5 mg Mounjaro overview covers what to expect at this level in more detail.

Spending four weeks here (sometimes longer if your prescriber recommends it) is standard practice. It is not a detour. It is the schedule working as designed.

Step 3, reaching 7.5 mg and what that step involves

Once you have completed at least four weeks at 5 mg without significant ongoing side effects, your prescriber can approve a move to 7.5 mg. At this point you will have been on Mounjaro for at least eight weeks. That timeline is not a bureaucratic delay; it reflects the fact that the body needs genuine time to adapt at each level.

For people who tolerated 5 mg very well, the 7.5 mg step is often smoother than earlier ones. The pattern of side effects (if any) typically follows the same arc: most noticeable in the first week or two after the increase, then settling. Nausea remains the most commonly reported complaint, alongside occasional fatigue or digestive changes. These are worth reporting to your clinical team but are not usually a reason to step back down unless they are persistent or severe.

If you are managing your treatment through nume, our clinical team reviews your progress before each repeat, a real prescriber reads your update, not a system that auto-processes it. A question our prescribers hear regularly is whether moving from 5 mg to 10 mg is an option for people who are tolerating treatment exceptionally well. The short answer: that is a clinical conversation, and it belongs in your consultation notes, not in a self-directed dose change.

For context on what happens when titration goes the other way, the page on dropping back from 5 mg to 2.5 mg explains the reasoning behind dose reductions.

What happens if you take a higher dose than prescribed

Taking 7.5 mg when your prescription says 2.5 mg or 5 mg is not a shortcut, it is taking the wrong dose of a prescription-only medicine. The risks are practical: significantly worse gastrointestinal side effects, possible dehydration from vomiting or diarrhoea, and the loss of the gradual adaptation that makes the medicine tolerable long-term. There is also no clinical evidence that jumping ahead accelerates weight loss in a meaningful way; what it reliably does is increase the chance of stopping treatment early because of side effects.

If you genuinely feel ready to move faster than the standard schedule, raise it with your prescriber. That is what the clinical review is for. At the same time, cost is sometimes a factor in these questions, if the price of sequential pens feels like an obstacle, the guide to Mounjaro costs in the UK sets out what drives pricing and what is included in a legitimate prescription service.

The pen you receive through a regulated pharmacy, arriving in plain packaging with DPD tracking, carries a specific strength on the label. That label is part of your prescription. It is not a suggestion.

If you are ready to discuss your titration journey with a prescriber, check your eligibility for a free consultation and a clinical review the same day.